Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03430154 · ClinicalTrials.gov registry record
Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)
A clinical trial of Haemophilia A, Haemophilia B, Obesity, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 317
- Enrollment target
- 1
- Study location
NCT03430154 is a study of Haemophilia A, Haemophilia B, Obesity that has completed, run by Novo Nordisk A/S. The registered enrollment target is 317 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03430154, a study of Haemophilia A, Haemophilia B, Obesity, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 317 participants
- Enrollment target
- 1
- Study location
Study Summary
An online web-based cross-sectional survey in which participants will complete a distinct questionnaire for patients with hemophilia and obesity (PwHO) and/or their carers/spouses/partners, or a distinct questionnaire for healthcare professionals. Each questionnaire consists of more than 100 items including pre-coded (multiple choice) closed-ended questions, yes/no questions and rating scales. It is estimated that this one-off survey will take approximately 45-60 minutes to complete. As a cross-sectional study, there will be no treatment of patients.
Conditions Studied
Interventions
- OTHER No treatment given
Study Locations (1)
New Jersey
- Novo Nordisk Investigational Site - Plainsboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 317 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2018-04-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03430154
The ClinicalTrials.gov registry entry for NCT03430154 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 317 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Haemophilia A, Haemophilia B, Obesity appearing as the primary indexed condition, and to 1 intervention - of which No treatment given is the first listed.
NCT03430154 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT03430154 about?
NCT03430154 is a clinical study titled "Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)". An online web-based cross-sectional survey in which participants will complete a distinct questionnaire for patients with hemophilia and obesity (PwHO) and/or their carers/spouses/partners, or a distinct questionnaire for healthcare professionals. Each questionnaire consists of more than 100 items i...
What is the current status of trial NCT03430154?
This trial is currently completed. The enrollment target is 317 participants. The study started on 2017-12-01. Estimated completion is 2018-04-29.
What conditions does trial NCT03430154 study?
This clinical trial studies the following conditions: Haemophilia A, Haemophilia B, Obesity.
What interventions are being tested in trial NCT03430154?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT03430154?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03430154 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.